关于 "Cell Cycle/Checkpoint" 的结果20+ 个结果
- DalpiciclibCAS: 1637781-04-4
Dalpiciclib (SHR-6390), a highly selective, orally bioavailable CDK4/6 inhibitor with comparable potencies against CDK4 and CDK6, exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated tumor-suppressor retinoblastoma protein (Rb) and inducing G1 cell cycle arrest. This product has poor solubility, animal experiments are available, cell experiments please choose carefully!
CDK - XL413 (BMS-863233)CAS: 1169562-71-3
XL413 (BMS-863233) is a potent and selective cell division cycle 7 homolog (CDC7) kinase inhibitor with IC50 of 3.4 nM, showing 63-, 12- and 35-fold selectivity over CK2, Pim-1 and pMCM2, respectively. Phase 1/2.
CDK - Samuraciclib hydrochloride (ICEC0942 hydrochloride)CAS: 1805789-54-1
Samuraciclib hydrochloride (ICEC0942 hydrochloride, CT7001 hydrochloride) is a new, orally bioavailable CDK7 inhibitor with an IC50 of 40nM. The IC50 values for CDK1, CDK2, CDK5 and CDK9 were 45-, 15-, 230- and 30-fold higher. ICEC0942 (CT7001) promotes cell cycle arrest and apoptosis.
CDK - PD 0332991 (Palbociclib) HClCAS: 827022-32-2
PD 0332991 作为 CDK4 和 CDK6 激酶的口服活性强效和高选择性抑制剂,可以在低纳摩尔浓度下阻断 pRb 磷酸化并随后在敏感细胞系中诱导 G1 期停滞。
CDK - Palbociclib (PD0332991) IsethionateCAS: 827022-33-3
Palbociclib (PD 0332991) isethionate 是一种具有口服活性的选择性 CDK4 和 CDK6 抑制剂,IC50 值分别为 11 和 16 nM。 Palbociclib (PD0332991) Isethionate 具有有效的抗增殖活性,可诱导癌细胞的细胞周期停滞,可用于 HR 阳性和 HER2 阴性乳腺癌和肝细胞癌的研究。
CDK - Roscovitine (Seliciclib,CYC202)CAS: 186692-46-6
Roscovitine (Seliciclib,CYC202)是一种有效的Cdk2/cyclin E抑制剂,IC 50 值为0.1μM。Roscovitine还抑制Cdk7/cyclin H、Cdk5/p35以及(cdc)/cyclin B,IC 50 值分别为0.49、0.16和0.65μM。
CDK
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GC16822 | LY2835219 | 1231930-82-7 | CDK | ||
LY2835219是 CDK4 和 CDK6 的强效选择性抑制剂,在非细胞实验中的 IC50 分别为 2nM 和 10nM。 | |||||
| GC17648 | Dinaciclib(SCH727965) | 779353-01-4 | Other Apoptosis | ||
A CDK inhibitor | |||||
| GC10842 | LEE011 | 1211441-98-3 | CDK | ||
LEE011是一种具有口服活性的特异性细胞周期蛋白依赖性激酶CDK4/6抑制剂。LEE011以纳摩尔浓度靶向cyclin D1/CDK4和cyclin D3/CDK6。 | |||||
| GC63419 | Dalpiciclib | 1637781-04-4 | CDK | ||
Dalpiciclib (SHR-6390), a highly selective, orally bioavailable CDK4/6 inhibitor with comparable potencies against CDK4 and CDK6, exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated tumor-suppressor retinoblastoma protein (Rb) and inducing G1 cell cycle arrest. This product has poor solubility, animal experiments are available, cell experiments please choose carefully! | |||||
| GC26084 | XL413 (BMS-863233) | 1169562-71-3 | CDK | ||
XL413 (BMS-863233) is a potent and selective cell division cycle 7 homolog (CDC7) kinase inhibitor with IC50 of 3.4 nM, showing 63-, 12- and 35-fold selectivity over CK2, Pim-1 and pMCM2, respectively. Phase 1/2. | |||||
| GC32735 | Samuraciclib hydrochloride (ICEC0942 hydrochloride) | 1805789-54-1 | CDK | ||
Samuraciclib hydrochloride (ICEC0942 hydrochloride, CT7001 hydrochloride) is a new, orally bioavailable CDK7 inhibitor with an IC50 of 40nM. The IC50 values for CDK1, CDK2, CDK5 and CDK9 were 45-, 15-, 230- and 30-fold higher. ICEC0942 (CT7001) promotes cell cycle arrest and apoptosis. | |||||
| GC15047 | PHA-793887 | 718630-59-2 | Other Apoptosis | ||
A CDK inhibitor | |||||
| GC12438 | AZD-5438 | 602306-29-6 | CDK | ||
A potent inhibitor of CDKs | |||||
| GC15588 | PHA-848125 | 802539-81-7 | Autophagy | ||
An inhibitor of Cdks | |||||
| GC16425 | Flavopiridol hydrochloride | 131740-09-5 | Autophagy | ||
An inhibitor of cyclin-dependent kinases | |||||
| GC15870 | AT7519 | 844442-38-2 | Other Apoptosis | ||
A Cdk inhibitor | |||||
| GC12865 | BMS265246 | 582315-72-8 | CDK | ||
A cell-permeable inhibitor of Cdk1 and Cdk2 | |||||
| GC17400 | R547 | 741713-40-6 | CDK | ||
A selective Cdk inhibitor | |||||
| GC13690 | BS-181 HCl | 1397219-81-6 | CDK | ||
A selective Cdk7 inhibitor | |||||
| GC17935 | PD 0332991 (Palbociclib) HCl | 827022-32-2 | CDK | ||
PD 0332991 作为 CDK4 和 CDK6 激酶的口服活性强效和高选择性抑制剂,可以在低纳摩尔浓度下阻断 pRb 磷酸化并随后在敏感细胞系中诱导 G1 期停滞。 | |||||
| GC12064 | SB1317 | 937270-47-8 | CDK | ||
A multi-kinase inhibitor | |||||
| GC13998 | AT7519 Hydrochloride | 902135-91-5 | Other Apoptosis | ||
A Cdk inhibitor | |||||
| GC11396 | SNS-032 (BMS-387032) | 345627-80-7 | Other Apoptosis | ||
A Cdk2, Cdk7, and Cdk9 inhibitor | |||||
| GC15421 | Palbociclib (PD0332991) Isethionate | 827022-33-3 | CDK | ||
Palbociclib (PD 0332991) isethionate 是一种具有口服活性的选择性 CDK4 和 CDK6 抑制剂,IC50 值分别为 11 和 16 nM。 Palbociclib (PD0332991) Isethionate 具有有效的抗增殖活性,可诱导癌细胞的细胞周期停滞,可用于 HR 阳性和 HER2 阴性乳腺癌和肝细胞癌的研究。 | |||||
| GC11401 | Roscovitine (Seliciclib,CYC202) | 186692-46-6 | CDK | ||
Roscovitine (Seliciclib,CYC202)是一种有效的Cdk2/cyclin E抑制剂,IC50值为0.1μM。Roscovitine还抑制Cdk7/cyclin H、Cdk5/p35以及(cdc)/cyclin B,IC50值分别为0.49、0.16和0.65μM。 | |||||
